AMPA receptors control fear extinction through an Arc-dependent mechanism

Learn Mem. 2017 Jul 17;24(8):375-380. doi: 10.1101/lm.045013.117. Print 2017 Aug.

Abstract

Activity-regulated cytoskeleton-associated protein (Arc) supports fear memory through synaptic plasticity events requiring actin cytoskeleton rearrangements. We have previously shown that reducing hippocampal Arc levels through antisense knockdown leads to the premature extinction of contextual fear. Here we show that the AMPA receptor antagonist CNQX elevates hippocampal Arc levels during extinction and blocks extinction that can be rescued by reducing Arc. Increasing Arc levels with CNQX also overcomes the actin-destabilizing properties of cytochalasin D and promotes extinction. Therefore, extinction is dependent on AMPA-mediated reductions of Arc via a mechanism consistent with a role for Arc in stabilizing the actin cytoskeleton to constrain extinction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Animals
  • Conditioning, Classical / drug effects
  • Conditioning, Classical / physiology
  • Cytochalasin D / pharmacology
  • Cytoskeletal Proteins / metabolism*
  • Excitatory Amino Acid Antagonists / pharmacology
  • Extinction, Psychological / drug effects
  • Extinction, Psychological / physiology*
  • Fear / drug effects
  • Fear / physiology*
  • Freezing Reaction, Cataleptic / drug effects
  • Freezing Reaction, Cataleptic / physiology
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Male
  • Nerve Tissue Proteins / metabolism*
  • Neuropsychological Tests
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Rats
  • Receptors, AMPA / antagonists & inhibitors
  • Receptors, AMPA / metabolism*

Substances

  • Cytoskeletal Proteins
  • Excitatory Amino Acid Antagonists
  • Nerve Tissue Proteins
  • Nucleic Acid Synthesis Inhibitors
  • Receptors, AMPA
  • activity regulated cytoskeletal-associated protein
  • Cytochalasin D
  • 6-Cyano-7-nitroquinoxaline-2,3-dione